Biopharmaceutical News

Latest News On Biopharmaceutical

MaxCyte to License Technology to TG Therapeutics for Development of Allogeneic CAR T Cell Therapy

MaxCyte to License Technology to TG Therapeutics for Development of Allogeneic CAR T Cell Therapy

2/13/2025 5:19 AM

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142

2/6/2025 12:54 PM

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis

11/25/2024 1:38 PM

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line

11/25/2024 1:36 PM

UCL scientists receive £78 million funding boost to develop treatment for motor neurone disease

UCL scientists receive £78 million funding boost to develop treatment for motor neurone disease

11/15/2024 1:04 AM

UAB researchers reverse liver disease in mice with gene therapy

UAB researchers reverse liver disease in mice with gene therapy

11/14/2024 5:17 AM

Adipo Therapeutics shares results of studies on potential obesity treatment

Adipo Therapeutics shares results of studies on potential obesity treatment

11/8/2024 4:20 AM

Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024

Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024

11/5/2024 11:13 AM

Study reveals key bacteria for developing personalized probiotics for newborns

Study reveals key bacteria for developing personalized probiotics for newborns

9/6/2024 4:15 PM

Waters new Rapid Screening-DSC enables up to 24x faster thermal stability testing at ultra-low sample volumes for antibody drugs

Waters new Rapid Screening-DSC enables up to 24x faster thermal stability testing at ultra-low sample volumes for antibody drugs

7/24/2024 11:53 AM

Enterprise Therapeutics doses first person with cystic fibrosis in phase 2 trial for novel therapy ETD001

Enterprise Therapeutics doses first person with cystic fibrosis in phase 2 trial for novel therapy ETD001

7/24/2024 10:54 AM

Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research

7/23/2024 1:25 PM

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

Almirall's Ebglyss recommended by NICE for NHS atopic dermatitis patients

7/13/2024 4:57 AM

Agreement to explore Optimer vehicles for targeted delivery of siRNA

Agreement to explore Optimer vehicles for targeted delivery of siRNA

7/9/2024 8:36 AM

WEHI spinout aims to revolutionize the development of cancer drugs

WEHI spinout aims to revolutionize the development of cancer drugs

6/20/2024 7:00 PM

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director

6/17/2024 12:53 PM

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

6/12/2024 11:02 AM

InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

6/7/2024 5:14 AM

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

6/4/2024 7:53 PM

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

UMSOM receives $3.96 million grant for maternal vaccine against neonatal sepsis

5/24/2024 1:36 AM

Render Time: 2025-02-14 13:22:12